Related Experiment Video
Updated: Aug 2, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Endothelial dysfunction and immunothrombosis in sepsis
Eleni Maneta1, Evmorfia Aivalioti1, Simon Tual-Chalot2
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Sepsis triggers immunothrombosis, leading to organ dysfunction. New therapies targeting immune responses and blood clotting show promise for improving sepsis outcomes.
Area of Science:
- Immunology
- Pathophysiology
- Pharmacology
Background:
- Sepsis is a critical condition with multiorgan dysfunction due to an overactive host response to infection.
- In sepsis, innate immune cells activate the coagulation cascade, causing immunothrombosis in microcirculation.
- While immunothrombosis can limit pathogen spread, it often leads to endothelial dysfunction and organ damage.
Purpose of the Study:
- To discuss mechanisms of organ-specific endothelial dysfunction and immunothrombosis in sepsis.
- To highlight recent therapeutic advances for sepsis complications.
Main Methods:
- Review of underlying mechanisms of sepsis-induced organ dysfunction.
- Analysis of immunothrombosis pathways.
- Discussion of novel therapeutic strategies targeting immune and coagulation pathways.
Main Results:
- Sepsis involves complex interactions between immune cells, endothelium, and coagulation.
- Endothelial dysfunction and microthrombosis are key drivers of organ damage in sepsis.
- Emerging therapies focus on modulating immune responses and platelet-endothelial interactions.
Conclusions:
- Understanding sepsis mechanisms is crucial for developing effective treatments.
- Targeting endothelial innate immunity and immunothrombosis offers potential for improved sepsis prognosis.
- Further research into novel therapeutic approaches is essential to reduce sepsis morbidity and mortality.
Related Concept Videos
Venous Thrombosis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Nephrotic Syndrome I : Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Kidney Injury II: Pathophysiology

